Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
JP Morgan Chase & Co GG Pref | JPM-J | Jan 10, 2025 | 20.71 | -2.13 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Jan 10, 2025 | 24.74 | -1.08 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Jan 10, 2025 | 55.98 | -1.48 |
Jumia Technologies ADR | JMIA | Jan 10, 2025 | 3.83 | -1.03 |
Junee Limited - Ordinary Shares | JUNE | Jan 10, 2025 | 3.42 | -1.72 |
Junior Gold Miners ETF Market Vectors | GDXJ | Jan 10, 2025 | 45.32 | -0.07 |
Juniper Networks | JNPR | Jan 10, 2025 | 38.45 | +0.21 |
Jupiter Neurosciences | JUNS | Jan 10, 2025 | 8.55 | 0.00 |
JVSPAC Acquisition | JVSAU | Jan 10, 2025 | 10.66 | 0.00 |
JVSPAC Acquisition | JVSA | Jan 10, 2025 | 10.49 | +0.10 |
JX Luxventure | JXG | Jan 10, 2025 | 3.38 | 0.00 |
JX Luxventure | JXJT | Jan 10, 2025 | 0.81 | 0.00 |
Kadant | KAI | Jan 10, 2025 | 340.97 | -1.21 |
Kairos Pharma | KAPA | Jan 10, 2025 | 0.97 | -5.83 |
Kairous Acquisition | KACL | Jan 10, 2025 | 12.33 | 0.00 |
Kaiser Aluminium | KALU | Jan 10, 2025 | 70.21 | -0.24 |
Kaival Brands Innovations Group | KAVL | Jan 10, 2025 | 1.12 | +12.00 |
Kaixin Holdings | KXIN | Jan 10, 2025 | 1.56 | +0.65 |
Kala Bio | KALA | Jan 10, 2025 | 6.81 | -0.15 |
Kaltura | KLTR | Jan 10, 2025 | 2.04 | -8.93 |
KalVista Pharmaceuticals | KALV | Jan 10, 2025 | 7.85 | -4.73 |
Kamada | KMDA | Jan 10, 2025 | 7.41 | +1.23 |
Kandi Technologies Group | KNDI | Jan 10, 2025 | 1.02 | -3.77 |
Kanzhun ADR | BZ | Jan 10, 2025 | 12.92 | -3.00 |
Karat Packaging | KRT | Jan 10, 2025 | 27.87 | -3.60 |
Karooooo | KARO | Jan 10, 2025 | 48.24 | -3.52 |
Kartoon Studios | TOON | Jan 10, 2025 | 0.54 | -5.09 |
Karyopharm Therapeutics | KPTI | Jan 10, 2025 | 0.72 | +0.36 |
Katapult | KPLT | Jan 10, 2025 | 6.41 | -5.69 |
Kayne Anderson BDC | KBDC | Jan 10, 2025 | 16.55 | -0.90 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.